| 1 |
前田愼. Helicobacter pyloriの基礎知識[J]. 臨床檢查, 2010, 54(2): 133-140.
|
| 2 |
Salama NR, Hartung ML, Muller A. Life the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori[J]. Nat Rev Microbiol, 2013, 11(6): 385-389.
|
| 3 |
Naumann M, Sokolova O, Tegtmeyer N, et al. Helicobacter pylori: A paradigm pathogen for subverting host cell signal transmission[J]. Trends Microbiol, 2017, 25(4): 316-328.
|
| 4 |
Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection[J]. Aliment Pharmacol Ther, 2018, 47(7): 868-876.
|
| 5 |
浅香正博. 我が国からの胃癌撲滅は可能か[J]. 日本臨牀, 2011, 69(1): 173-182.
|
| 6 |
肖玲巧, 王 超, 谢成元, 等. 幽门螺杆菌Tipα蛋白激活NLRP3炎性小体诱导THP-1细胞分泌IL-1Β和IL-18[J]. 中国人兽共患病学报, 2017, 33(12): 1071-1076.
|
| 7 |
胡洁, 孙哲, 梅林. 幽门螺杆菌细胞毒导致胃癌发生的作用机制[J]. 中国药理学通报, 2014, 30(2): 156-159.
|
| 8 |
Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in Helicobacter pylori[J]. J Dig Dis, 2013, 14(7): 341-349.
|
| 9 |
De Brito BB, Da Silva FAF, De Melo FF. Role of poly-morphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis[J]. World J Clin Oncol, 2018, 9 (5): 83-89.
|
| 10 |
Mcclain MS, Beckett AC. Helicobacter pylori Vacuola-ting Toxin and Gastric Cancer[J]. Toxins, 2017, 9 (10): 316-333.
|
| 11 |
Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer[J]. Dig Dis, 2014, 32(3): 249-264.
|
| 12 |
Timothy L. Helicobacter pylori diversity and gastric cancer risk[J]. MBIO, 2016, 7(1): 1869-1884.
|
| 13 |
El Khadir M, Alaoui BS, Benajah DA, et al. VacA and cagA status as biomarker of two opposite end outcomes of Helicobacter pylori lntection (gastric cancer and duodenal ulcer) in a moroccan population[J]. pLoS One, 2017, 12(10): e0170616.
|
| 14 |
Bibi F, Alvi SA, Sawan SA, et al. Detection and genotyping of Helicobacter pylori among gastric ulcer and cancer patients from Saudi Arabia[J]. Pak J Med Sci, 2017, 33(2): 320-324.
|
| 15 |
杨彪, 李明, 谭诗云. 幽门螺杆菌定植因子研究进展[J]. 胃肠病学和肝病学杂志, 2021, 30(10): 1178-1182.
|
| 16 |
丸澤宏之. H. pylori感染からの胃がん発生機構[J]. 癌と化学療法, 2010, 37(1): 23-27.
|
| 17 |
Wroblewski LE, Shen L, Ogden S, et al. Helicobacter pylori dysregulation of gastric epithelial tight junctions by urease-mediated myosin Ⅱ activation[J]. Gastroenterology, 2009, 136(1): 236-246.
|
| 18 |
Tsugawa H, Mori H, Matsuzaki J, et al. Nordihydroguaiaretic acid disrupts the antioxidant ability of Helicobacter pylori through the repression of SODB activity in vitro[J]. Biomed Res Int, 2015, 201(12): 7345-7348.
|
| 19 |
Dunne C, Dolan B, Clyne M. Factors that mediate colonization of the human stomach by Helicobacter pylori[J]. World J Gastroenterol, 2014, 20(19): 5610-5624.
|
| 20 |
Hage N, Howard T, Phillips C, et al. Structural basis of Lewis (b) antigen binding by the Helicobacter pylori adhesin BabA[J]. Sci Adv, 2015, 1(7): e1500315.
|
| 21 |
Worku MK, Sidebotham RL, Walker MM, et al. The relationship between Helicobacter pylori motility, morphology and phase of growth: implications for gastric colonization and pathology[J]. Microbiology, 1999, 145(10): 2803-2811.
|
| 22 |
罗微, 王倩, 陈铁龙. 幽门螺杆菌鞭毛研究概述[J]. 中国病原生物学杂志, 2015, 10(9): 852-857.
|
| 23 |
Markelova N. Interaction of bdellovibrio bacteriovorus with bacteria campylobacter jejuni and helicobacter pylori[J]. Mikrobiologiia, 2010, 79(6): 777-779.
|
| 24 |
Isomoto H, Moss J, Hiravama T. Pleiotropic actions of helicobacter pylori vacuolating cytotoxin, VacA[J]. Tohoku J Exp Med, 2010, 22(1): 3-14.
|
| 25 |
Rudnicka K, Wlodarczyk M, Moran AP, et al. Helicobacter pylori antigens as potential modulators of lymphocytes cytotoxic activity[J]. Microbiol Immunol, 2012,56(1): 62-75.
|
| 26 |
田新利, 刘东, 郭玲, 等. 幽门螺杆菌胶原蛋白酶Hp PrtC的表达、纯化及结晶尝试[J]. 中国病原生物学杂志, 2018, 13(7): 719-723.
|
| 27 |
Shiota S, Suzuki R, Yamaoka Y. The significance of virulence factors in helicobacter pylori[J]. J Dig Dis, 2013, 14(7): 341-349.
|
| 28 |
Percival SL, Suleman L. Biofilms and helicobacter pylori: dissemination and persistence within the environment and host[J]. World J Gastrointest Pathophysiol, 2014, 5(3): 122-132.
|
| 29 |
Yip HC, Teoh AYB. Importance of timely eradication of helicobacter pylori to prevent peptic ulcer recurrence and gastric cancer[J]. Gastrointest Endosc, 2018, 88(2): 251-252.
|
| 30 |
廖远泉, 王玲玲, 郭喜, 等. 幽门螺杆菌感染研究应重视的问题——与"幽门螺杆菌经呼吸道传播的设想"研究者的商榷[J]. 医学争鸣, 2019, 10(6): 18-21.
|
| 31 |
廖远泉, 鲍旭. 幽门螺杆菌感染全民根除治疗及其对"微生态系统"平衡的影响[J]. 医学争鸣, 2020, 11(4): 51-54, 57.
|
| 32 |
袁天峰, 吴涛, 刘佳倩, 等. 明辨是非繁荣医学学术思想碰撞助推医学发展—《医学争鸣》杂志刊发重要学术观点评述[J]. 医学争鸣, 2021, 12(2): 1-10.
|
| 33 |
林俊治. Helicobacter pylori感染と免疫応答[J]. 臨床檢查, 2010, 54(2): 151-157.
|
| 34 |
廖远泉. 贯彻落实我国重大传染病预防与控制措施, 不忘初心开创检验医学新征程[J]. 实用检验医师杂志, 2021,13(3): 139-142.
|